International Clinical Psychopharmacology

Current Issue

July 2023 - Volume 38 - Issue 4

Editor-in-Chief: Alessandro Serretti
ISSN: 0268-1315
Online ISSN: 1473-5857
Frequency: 6 issues / year
Ranking: 132 of 155 Psychiatry
232 of 279 Pharmacology & Pharmacy
Impact Factor: 2.023

Editorial

Debated issues in major psychoses

Serretti, Alessandro

International Clinical Psychopharmacology. 38(4):201-203, July 2023.

PDF
Permissions

Original Articles

Clinical correlates and prognostic implications of severe suicidal ideation in major depressive disorder

Olgiati, Paolo; Fanelli, Giuseppe; Serretti, Alessandro

International Clinical Psychopharmacology. 38(4):201-208, July 2023.

Open

Frequency, risk factors, and impacts on quality of life of the restless legs syndrome and side effects among antidepressant users in a tertiary hospital: an observational cross-sectional study

Cetin Erdem, Hatice; Kara, Huseyin; Ozcelik, Ozgen; More

International Clinical Psychopharmacology. 38(4):209-215, July 2023.

Review

Efficacy and safety profiles of mood stabilizers and antipsychotics for bipolar depression: a systematic review

Cai, Luyao; Chen, Guanjie; Yang, Haichen; More

International Clinical Psychopharmacology. 38(4):249-260, July 2023.

Meta-Analysis

Phosphodiesterase inhibitor and selective serotonin reuptake inhibitor combination therapy versus monotherapy for the treatment of major depressive disorder: a systematic review and meta-analysis

Nawras, Mohamad; Beran, Azizullah; Yazdi, Vahid; More

International Clinical Psychopharmacology. 38(4):261-268, July 2023.

Case Reports

Hyperthyroidism and depression: a clinical case of atypical thyrotoxicosis manifestation

Chiera, Martina; Draghetti, Stefano; De Ronchi, Diana; More

International Clinical Psychopharmacology. 38(4):269-272, July 2023.

Remission of treatment-resistant obsessive-compulsive disorder with 600 milligrams of fluvoxamine daily: a case report

Kocamer Şahin, Şengül; Demir, Bahadir; Altindağ, Abdurrahman

International Clinical Psychopharmacology. 38(4):273-274, July 2023.

Journal Statistics

Acceptance rate: 60%

Average time for first decision: 6 weeks (excluding articles declined immediately in less than 1 week).

Average time to final decision for accepted articles: 7 weeks (excluding time for revision)

Click on the link below to submit your manuscript to International Clinical Psychopharmacology.

Secondary Logo

Journal Logo